Finance

Lists
Outlook: 57.7% bullish·7.7% bearish
Go to analysis
LQDA:NASDAQ
Liquidia Corp
$57.41
-1.22%
(-0.71) 1D
$56.92
-0.85% (-0.49)
After hours
Closed: Nov 13, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LQDA...
Open
$58.37
High
$59.50
Low
$57.00
Mkt. cap
5.17B
Avg. vol.
4.66M
Volume
1.93M
52-wk high
$93.61
52-wk low
$22.31
EPS
-$1.21
Beta
0.40
Shares outstanding
90.11M
No. of employees
216
Open
$58.37
High
$59.50
Low
$57.00
Mkt. cap
5.17B
Avg. vol.
4.66M
Volume
1.93M
52-wk high
$93.61
52-wk low
$22.31
EPS
-$1.21
Beta
0.40
Shares outstanding
90.11M
No. of employees
216
News stories
From web sources and news partners
About Liquidia Corp
CEO-
Employees216
Founded2004
HeadquartersMorrisville, North Carolina, United States
SectorHealth Care
IndustryPharmaceutical industry
Websiteliquidia.com
Analyst ratings
Based on 8 analysts giving stock ratings to LQDA in the past 3 months
Strong buy
Buy
6
Hold
2
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for LQDA in the last 3 months.
Highest
Current $57.41
$87.00 (+51.54%)
Average
$64.13 (+11.71%)
Lowest
$40.00 (-30.33%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matthew Caufield
H.C. Wainwright
Buy
Initiated
$76.00
+32.4%
11/13/2026
Ryan Deschner
Raymond James
Buy
Maintained
$77.00
+34.1%
11/11/2026
Jason Gerberry
Bank of America Securities
Hold
Reiterated
$54.00
-5.9%
11/11/2026
Julian Harrison
BTIG
Buy
Reiterated
$87.00
+51.5%
11/10/2026
Benjamin Burnett
Wells Fargo
Hold
Maintained
$40.00
-30.3%
11/11/2026
Amy Li
Jefferies
Buy
Maintained
$62.00
+8%
11/10/2026
Andrew Fein
H.C. Wainwright
Buy
Reiterated
$65.00
+13.2%
10/15/2026
Gaurav Maini
LifeSci Capital
Buy
Upgraded
$59.00
+2.8%
10/14/2026
Serge Belanger
Needham
Buy
Maintained
$58.00
+1%
10/14/2026
Unknown Analyst
Wells Fargo
Buy
Maintained
$51.00
-11.2%
04/01/2026
Andreas Argyrides
Oppenheimer
Sell
Maintained
$19.00
-66.9%
03/12/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
92.02M
132.86M
171.68M
225.30M
Cost of goods sold
7.06M
11.85M
11.55M
14.78M
Cost of revenue
7.06M
11.85M
11.55M
14.78M
Research and development expenses
16.94M
12.22M
17.18M
25.27M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
48.24M
47.29M
57.43M
59.02M
Operating expense
65.18M
59.51M
74.61M
84.29M
Total operating expenses
72.23M
71.36M
86.16M
99.07M
Operating income
19.79M
61.50M
85.52M
126.23M
Other non operating income
-
-
-
-
EBT including unusual items
14.56M
56.78M
81.70M
-266.40M
EBT excluding unusual items
14.56M
56.78M
81.70M
123.35M
Income tax expense
-
3.92M
6.98M
-30.07M
Effective tax rate
-
6.90%
8.54%
11.29%
Other operating expenses
-
-
-
-
Net income
14.56M
52.86M
74.72M
-236.33M
Net profit margin
15.82%
39.79%
43.52%
-104.89%
Earnings per share
0.15
0.52
0.74
1.22
Interest and investment income
1.67M
1.77M
2.48M
-
Interest expense
-6.90M
-6.49M
-6.30M
-2.88M
Net interest expenses
-5.23M
-4.72M
-3.82M
-2.88M
Depreciation and amortization charges
-
-
-
-
EBITDA
20.01M
61.90M
85.82M
126.48M
Gain or loss from assets sale
11.00K
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps